CVS HEALTH Corp - Common Stock (CVS)

Historical Holders from Q1 2014 to Q1 2025

Symbol
CVS on NYSE
CUSIP
126650100
Type / Class
Equity / Common Stock
Shares outstanding
1.26B
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
1.04B
Holdings value
$46.9B
% of all portfolios
0.038%
Grand Portfolio weight change
+0.003%
Number of holders
1622
Number of buys
446
Number of sells
-1272
Average Value change %
-0.01%
Average buys %
+0.009%
Average sells %
-0.022%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CVS HEALTH Corp - Common Stock (CVS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.1% $6.04B 89.2M BlackRock, Inc. Mar 31, 2025

Institutional Holders of CVS HEALTH Corp - Common Stock (CVS)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 20.7M $1.4B +$235M $67.75 373
2024 Q4 1.04B $46.9B +$1.64B $44.89 1,622
2024 Q3 999M $62.9B -$1.66B $62.88 1,812
2024 Q2 1.02B $60.2B +$1.94B $59.06 1,861
2024 Q1 988M $78.7B -$2.13B $79.76 2,128
2023 Q4 1.01B $80.1B +$2.64B $78.96 2,192
2023 Q3 981M $68.5B +$508M $69.82 2,057
2023 Q2 975M $67.5B -$1.35B $69.13 2,146
2023 Q1 967M $71.8B -$2.21B $74.31 2,201
2022 Q4 1.02B $95.2B -$548M $93.19 2,350
2022 Q3 1.03B $98.5B +$721M $95.37 2,279
2022 Q2 1B $92.5B +$139M $92.66 2,259
2022 Q1 1.01B $103B +$223M $101.21 2,316
2021 Q4 1.01B $104B +$841M $103.16 2,295
2021 Q3 1.01B $86.2B +$21.2M $84.86 2,037
2021 Q2 1.02B $84.7B +$2.04B $83.44 2,033
2021 Q1 992M $74.6B +$62.7M $75.23 2,001
2020 Q4 980M $67B +$51.5M $68.30 1,937
2020 Q3 991M $57.8B -$1.25B $58.40 1,785
2020 Q2 1.01B $65.8B +$787M $64.97 1,833
2020 Q1 994M $58.9B -$645M $59.33 1,773
2019 Q4 1.01B $74.8B +$96.5M $74.29 1,810
2019 Q3 1.01B $63.5B +$667M $63.07 1,658
2019 Q2 970M $52.9B +$696M $54.49 1,628
2019 Q1 1.01B $54.7B -$2.46B $53.93 1,675
2018 Q4 1.06B $69.1B +$12.1B $65.52 1,754
2018 Q3 865M $68.1B +$1.78B $78.72 1,581
2018 Q2 849M $54.6B +$905M $64.35 1,547
2018 Q1 838M $52.1B -$333M $62.21 1,522
2017 Q4 843M $61.1B +$1.05B $72.50 1,577
2017 Q3 836M $68B +$43.1M $81.32 1,513
2017 Q2 836M $67.2B -$547M $80.46 1,537
2017 Q1 843M $66.2B +$3.27B $78.50 1,560
2016 Q4 862M $68B -$1.08B $78.91 1,529
2016 Q3 872M $77.6B +$113M $88.99 1,544
2016 Q2 870M $83.3B -$2.2B $95.74 1,555
2016 Q1 889M $92.2B -$2.3B $103.73 1,540
2015 Q4 918M $89.8B -$1.17B $97.77 1,539
2015 Q3 930M $89.8B +$453M $96.48 1,490
2015 Q2 915M $95.9B -$527M $104.88 1,463
2015 Q1 939M $96.9B -$2.02B $103.21 1,438
2014 Q4 959M $92.4B -$1.33B $96.31 1,399
2014 Q3 968M $77B -$334M $79.59 1,277
2014 Q2 968M $72.9B -$1.52B $75.37 1,253
2014 Q1 961M $71.9B -$780M $74.86 1,216